These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 34592340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C, Li M, Guo T, Wang S, Huang W, Yang K, Liao Z, Wang J, Zhang F, Wang H.
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD, Liu XE, Huang DS.
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [Abstract] [Full Text] [Related]

  • 5. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
    Cao L, Xiao X, Lei J, Duan W, Ma Q, Li W.
    Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
    [Abstract] [Full Text] [Related]

  • 6. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
    Koike Y, Ohta Y, Saitoh W, Yamashita T, Kanomata N, Moriya T, Kurebayashi J.
    Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
    [Abstract] [Full Text] [Related]

  • 7. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers.
    Di Mauro C, Rosa R, D'Amato V, Ciciola P, Servetto A, Marciano R, Orsini RC, Formisano L, De Falco S, Cicatiello V, Di Bonito M, Cantile M, Collina F, Chambery A, Veneziani BM, De Placido S, Bianco R.
    Br J Cancer; 2017 May 23; 116(11):1425-1435. PubMed ID: 28441382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Antimicrobial Peptide Merecidin Inhibit the Metastasis of Triple-Negative Breast Cancer by Obstructing EMT via miR-30d-5p/Vimentin.
    Ma F, Song J, He M, Wang X.
    Technol Cancer Res Treat; 2024 May 23; 23():15330338241281310. PubMed ID: 39267432
    [Abstract] [Full Text] [Related]

  • 10. [En1 promotes cell proliferation and migration via Hedgehog signaling pathway in esophageal squamous cell carcinoma].
    Zhao N, Gong TY, Wei ZC, Cong J, Liu ZH, Chen HY.
    Zhonghua Zhong Liu Za Zhi; 2024 Feb 23; 46(2):99-107. PubMed ID: 38418183
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. GLI1 is involved in HIF-1α-induced migration, invasion, and epithelial-mesenchymal transition in glioma cells.
    Lin Y, Guo L.
    Folia Histochem Cytobiol; 2022 Feb 23; 60(2):156-166. PubMed ID: 35603730
    [Abstract] [Full Text] [Related]

  • 13. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M, Fu Y, Yan Y, Xiao Q, Wu H, Yao W, Zhao H, Zhao L, Jiang Q, Yu Z, Jin F, Mi X, Wang E, Cui Z, Fu L, Chen J, Wei M.
    Clin Sci (Lond); 2015 Nov 23; 129(9):809-22. PubMed ID: 26201092
    [Abstract] [Full Text] [Related]

  • 14. Cordycepin Inhibits Growth and Metastasis Formation of MDA-MB-231 Xenografts in Nude Mice by Modulating the Hedgehog Pathway.
    Wu W, Li X, Qi M, Hu X, Cao F, Wu X, Fu J.
    Int J Mol Sci; 2022 Sep 08; 23(18):. PubMed ID: 36142286
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins.
    Lu H, Wu Z, Wang Y, Zhao D, Zhang B, Hong M.
    Phytomedicine; 2022 Sep 08; 104():154291. PubMed ID: 35839735
    [Abstract] [Full Text] [Related]

  • 17. Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer.
    Riaz SK, Khan JS, Shah STA, Wang F, Ye L, Jiang WG, Malik MFA.
    Cell Commun Signal; 2018 Jan 08; 16(1):3. PubMed ID: 29329585
    [Abstract] [Full Text] [Related]

  • 18. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
    Zhou DD, Bai WQ, Zhai XT, Sun LP, Zhen YS, Li ZR, Miao QF.
    Mil Med Res; 2021 Dec 09; 8(1):63. PubMed ID: 34879870
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
    Benvenuto M, Masuelli L, De Smaele E, Fantini M, Mattera R, Cucchi D, Bonanno E, Di Stefano E, Frajese GV, Orlandi A, Screpanti I, Gulino A, Modesti A, Bei R.
    Oncotarget; 2016 Feb 23; 7(8):9250-70. PubMed ID: 26843616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.